Vegezzi, Elisa
Cortese, Andrea
Bergsland, Niels
Mussinelli, Roberta
Paoletti, Matteo
Solazzo, Francesca
Currò, Riccardo
Ascagni, Lucia
Callegari, Ilaria
Quartesan, Ilaria
Lozza, Alessandro
Deligianni, Xeni
Santini, Francesco
Marchioni, Enrico
Cosentino, Giuseppe
Alfonsi, Enrico
Tassorelli, Cristina
Bastianello, Stefano
Merlini, Giampaolo
Palladini, Giovanni
Obici, Laura
Pichiecchio, Anna
Funding for this research was provided by:
Fondazione Regionale per la Ricerca Biomedica (1751723)
Medical Research Council (MR/T001712/1)
Fondazione CARIPLO (2019-1836, 2018-0257, 2018-0257)
Inherited Neuropathy Consortium
Italian Ministry of Health (RC 2017-2019/RC 2020, RC 2017-2019/RC 2020)
Italian Medicines Agency (AIFA-2016-02364602, AIFA-2016-02364602)
European Academy of Neurology (Research Fellowship 2021)
Università degli Studi di Pavia
Article History
Received: 21 May 2022
Revised: 9 August 2022
Accepted: 10 August 2022
First Online: 6 September 2022
Declarations
:
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethic Committee of IRCCS Fondazione Policlinico S. Matteo (p-20170020469) and by local institutional review boards.
: Informed consent was obtained from all individual participants included in the study.